Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models

Immune checkpoint blockade (ICB) therapies have had a tremendous impact on cancer therapy. However, most patients harbor a poorly immunogenic tumor microenvironment (TME), presenting overwhelming de novo refractoriness to ICB inhibitors. To address these challenges, combinatorial regimens that emplo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaowei, Shu, Liwei, Wang, Minwen, Yao, Jie, Yao, Qigu, Bian, Suchen, Chen, Xiaona, Wan, Jianqin, Zhang, Fu, Zheng, Shusen, Wang, Hangxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214259/
https://www.ncbi.nlm.nih.gov/pubmed/37017572
http://dx.doi.org/10.1002/advs.202204890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214259/
https://www.ncbi.nlm.nih.gov/pubmed/37017572
http://dx.doi.org/10.1002/advs.202204890

Ejemplares similares